Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
More people are getting cancer in their 20s, 30s, and 40s, and surviving, thanks to rapid advancement in care. Many will have decades of life ahead of them, which means they face greater and more complex challenges in survivorship. Lourdes Monje is navigating these waters at age 29. -
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages. -
Nearly half of women over 40 have dense breasts, which raises their risk of breast cancer. Mammograms should now include an assessment of breast tissue density. -
President Biden traveled to New Orleans this week to announce a $150 million investment in technologies to improve cancer surgeries. We check in on the progress of Cancer Moonshot.
-
Drug overdoses on college campuses are not tracked, and rarely publicized, as colleges cite health privacy laws. But advocates are working to make overdose reversal treatment widely available on campus. -
As overdose kills more young people, some colleges and students are finding ways to better respond. A group is organizing students on 28 campuses to distribute and use Narcan.
-
Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity. -
Seven million pounds of deli meat has been recalled by Boar's Head because of listeria risk. The meat was sold all over the country.
-
The influential US Preventive Services Task Force urged behavioral counseling for children and teens with very high BMI. Notably the group did not include Ozempic-like drugs in the recommendation. -
There are lots of reasons people have to stop taking the new weight loss drugs: cost, shortages, side effects and life events. And the weight usually comes back, doctors say.
